Otsuka Sues Orchid Pharma to Halt Generic Abilify
By Cristina Violante ( January 26, 2016, 7:41 PM EST) -- Otsuka Pharmaceutical Co. Ltd. has hit Indian drug maker Orchid Pharma Ltd. and its subsidiaries with two patent suits in New Jersey federal court over generic versions of the high-selling antipsychotic Abilify....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.